Efficacy and safety of immune checkpoint inhibitors in solid tumor patients combined with chronic coronary syndromes or its risk factor: a nationwide multicenter cohort study.
Liu C, Ruan Y, Huang R, Fang L, Wu T, Lv Y, Cui L, Liao Y, Wang B, Chen Z, Su D, Ma Y, Han S, Guan X, Cui J, Yao Y, Wang Y, Wang M, Liu R, Zhang Y.
Liu C, et al. Among authors: wang y, wang m, wang b.
Cancer Immunol Immunother. 2024 Jun 8;73(8):159. doi: 10.1007/s00262-024-03747-w.
Cancer Immunol Immunother. 2024.
PMID: 38850359
Free PMC article.